151 related articles for article (PubMed ID: 9442787)
41. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
42. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
43. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
Lawson BM; Saktanasate J; Say EA; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
[TBL] [Abstract][Full Text] [Related]
44. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
45. Thermochemotherapy in hereditary retinoblastoma.
Schueler AO; Jurklies C; Heimann H; Wieland R; Havers W; Bornfeld N
Br J Ophthalmol; 2003 Jan; 87(1):90-5. PubMed ID: 12488270
[TBL] [Abstract][Full Text] [Related]
46. Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
Pavlidou E; Burris C; Thaung C; Scheimberg I; Kingston J; Hungerford JL; Reddy MA; Sagoo MS
JAMA Ophthalmol; 2015 Dec; 133(12):1455-8. PubMed ID: 26334520
[TBL] [Abstract][Full Text] [Related]
47. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.
Levy C; Doz F; Quintana E; Pacquement H; Michon J; Schlienger P; Validire P; Asselain B; Desjardins L; Zucker JM
Br J Ophthalmol; 1998 Oct; 82(10):1154-8. PubMed ID: 9924303
[TBL] [Abstract][Full Text] [Related]
48. Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.
Abramson DH; Marr BP; Dunkel IJ; Brodie S; Zabor EC; Driscoll SJ; Gobin YP
Br J Ophthalmol; 2012 Apr; 96(4):499-502. PubMed ID: 22053101
[TBL] [Abstract][Full Text] [Related]
49. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
[TBL] [Abstract][Full Text] [Related]
50. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
51. Chemoreduction in the management of retinoblastoma.
Shields JA; Shields CL; Meadows AT
Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
[No Abstract] [Full Text] [Related]
52. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
[TBL] [Abstract][Full Text] [Related]
53. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
[TBL] [Abstract][Full Text] [Related]
54. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
56. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma.
Wilson MW; Rodriguez-Galindo C; Haik BG; Moshfeghi DM; Merchant TE; Pratt CB
Ophthalmology; 2001 Nov; 108(11):2106-14; discussion 2114-5. PubMed ID: 11713087
[TBL] [Abstract][Full Text] [Related]
57. New retinoblastoma tumors in children undergoing systemic chemotherapy.
Scott IU; Murray TG; Toledano S; O'Brien JM
Arch Ophthalmol; 1998 Dec; 116(12):1685-6. PubMed ID: 9869808
[No Abstract] [Full Text] [Related]
58. Conjunctival melanoma 3 years after radiation and chemotherapy for retinoblastoma.
Mahajan A; Shields CL; Eagle RC; Mashayekhi A; Freire JE; Shields JA
J Pediatr Ophthalmol Strabismus; 2007; 44(5):300-2. PubMed ID: 17913173
[TBL] [Abstract][Full Text] [Related]
59. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
60. [Conservative treatment in patients with unilateral retinoblastoma].
Rutynowska-Pronicka O; Hautz W; Brozyna A; Dembowska-Bagińska B; Drogosiewicz M; Stypińska M; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):655-63. PubMed ID: 17317897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
